Literature DB >> 24302721

Phosphorylation of CEACAM1 molecule by calmodulin kinase IID in a three-dimensional model of mammary gland lumen formation.

Tung Nguyen1, Charng-Jui Chen, John E Shively.   

Abstract

Carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1), a transmembrane protein, expressed on normal breast epithelial cells is down-regulated in breast cancer. Phosphorylation of Thr-457 on the short cytoplasmic domain isoform (CEACAM1-SF) that is predominant in normal epithelial cells is required for lumen formation in a three-dimensional model that involves apoptosis of the central acinar cells. Calmodulin kinase IID (CaMKIID) was selected as a candidate for the kinase required for Thr-457 phosphorylation from a gene chip analysis comparing genes up-regulated in MCF7 cells expressing wild type CEACAM1-SF compared with the T457A-mutated gene (Chen, C. J., Kirshner, J., Sherman, M. A., Hu, W., Nguyen, T., and Shively, J. E. (2007) J. Biol. Chem. 282, 5749-5760). Up-regulation of CaMKIID during lumen formation was confirmed by analysis of mRNA and protein levels. CaMKIID was able to phosphorylate a synthetic peptide corresponding to the cytoplasmic domain of CEACAM1-SF and was covalently bound to biotinylated and T457C-modified peptide in the presence of a kinase trap previously described by Shokat and co-workers (Maly, D. J., Allen, J. A., and Shokat, K. M. (2004) J. Am. Chem. Soc. 126, 9160-9161). When cell lysates from wild type-transfected MCF7 cells undergoing lumen formation were incubated with the peptide and kinase trap, a cross-linked band corresponding to CaMKIID was observed. When these cells were treated with an RNAi that inhibits CaMKIID expression, lumen formation was blocked by over 90%. We conclude that CaMKIID specifically phosphorylates Thr-457 on CEACAM1-SF, which in turn regulates the process of lumen formation via apoptosis of the central acinar cells.

Entities:  

Keywords:  Apoptosis; Breast Cancer; CaMKII; Calmodulin; Cell Adhesion; RNA Interference (RNAi)

Mesh:

Substances:

Year:  2013        PMID: 24302721      PMCID: PMC3908425          DOI: 10.1074/jbc.M113.496992

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

Review 1.  Structure-function of the multifunctional Ca2+/calmodulin-dependent protein kinase II.

Authors:  Andy Hudmon; Howard Schulman
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

2.  The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini.

Authors:  Jayanta Debnath; Kenna R Mills; Nicole L Collins; Mauricio J Reginato; Senthil K Muthuswamy; Joan S Brugge
Journal:  Cell       Date:  2002-10-04       Impact factor: 41.582

3.  A mechanism-based cross-linker for the identification of kinase-substrate pairs.

Authors:  Dustin J Maly; Jasmina A Allen; Kevan M Shokat
Journal:  J Am Chem Soc       Date:  2004-08-04       Impact factor: 15.419

4.  A sensitive method for detection of calmodulin-dependent protein kinase II activity in sodium dodecyl sulfate-polyacrylamide gel.

Authors:  I Kameshita; H Fujisawa
Journal:  Anal Biochem       Date:  1989-11-15       Impact factor: 3.365

5.  Carcinoembryonic antigen cell adhesion molecule 1 directly associates with cytoskeleton proteins actin and tropomyosin.

Authors:  D Schumann; C J Chen; B Kaplan; J E Shively
Journal:  J Biol Chem       Date:  2001-10-10       Impact factor: 5.157

6.  Inside-out signaling promotes dynamic changes in the carcinoembryonic antigen-related cellular adhesion molecule 1 (CEACAM1) oligomeric state to control its cell adhesion properties.

Authors:  Prerna C Patel; Hannah S W Lee; Aaron Y K Ming; Arianna Rath; Charles M Deber; Christopher M Yip; Jonathan V Rocheleau; Scott D Gray-Owen
Journal:  J Biol Chem       Date:  2013-09-04       Impact factor: 5.157

Review 7.  The organizing principle: microenvironmental influences in the normal and malignant breast.

Authors:  Mina J Bissell; Derek C Radisky; Aylin Rizki; Valerie M Weaver; Ole W Petersen
Journal:  Differentiation       Date:  2002-12       Impact factor: 3.880

8.  Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is required for induction of autophagy during lumen formation in vitro.

Authors:  Kenna R Mills; Mauricio Reginato; Jayanta Debnath; Bridget Queenan; Joan S Brugge
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-01       Impact factor: 11.205

9.  CEACAM1-4S, a cell-cell adhesion molecule, mediates apoptosis and reverts mammary carcinoma cells to a normal morphogenic phenotype in a 3D culture.

Authors:  Julia Kirshner; Charng-Jui Chen; Pingfang Liu; Jie Huang; John E Shively
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-09       Impact factor: 11.205

10.  Essential role of biliary glycoprotein (CD66a) in morphogenesis of the human mammary epithelial cell line MCF10F.

Authors:  J Huang; J D Hardy; Y Sun; J E Shively
Journal:  J Cell Sci       Date:  1999-12       Impact factor: 5.285

View more
  11 in total

1.  NMR analysis of free and lipid nanodisc anchored CEACAM1 membrane proximal peptides with Ca2+/CaM.

Authors:  Haike Ghazarian; Weidong Hu; Allen Mao; Tung Nguyen; Nagarajan Vaidehi; Stephen Sligar; John E Shively
Journal:  Biochim Biophys Acta Biomembr       Date:  2019-01-10       Impact factor: 3.747

2.  miRNA-342 Regulates CEACAM1-induced Lumen Formation in a Three-dimensional Model of Mammary Gland Morphogenesis.

Authors:  Chunyue Weng; Tung Nguyen; John E Shively
Journal:  J Biol Chem       Date:  2016-06-14       Impact factor: 5.157

Review 3.  CEACAM1 structure and function in immunity and its therapeutic implications.

Authors:  Walter M Kim; Yu-Hwa Huang; Amit Gandhi; Richard S Blumberg
Journal:  Semin Immunol       Date:  2019-04       Impact factor: 11.130

4.  Induction of Lumen Formation in a Three-dimensional Model of Mammary Morphogenesis by Transcriptional Regulator ID4: ROLE OF CaMK2D IN THE EPIGENETIC REGULATION OF ID4 GENE EXPRESSION.

Authors:  Tung Nguyen; John E Shively
Journal:  J Biol Chem       Date:  2016-06-14       Impact factor: 5.157

5.  Structural characterization of a dimeric complex between the short cytoplasmic domain of CEACAM1 and the pseudo tetramer of S100A10-Annexin A2 using NMR and molecular dynamics.

Authors:  Weidong Hu; Supriyo Bhattacharya; Teresa Hong; Patty Wong; Lin Li; Nagarajan Vaidehi; Markus Kalkum; John E Shively
Journal:  Biochim Biophys Acta Biomembr       Date:  2020-08-21       Impact factor: 3.747

6.  Loss of CEACAM1, a Tumor-Associated Factor, Attenuates Post-infarction Cardiac Remodeling by Inhibiting Apoptosis.

Authors:  Yan Wang; Yanmei Chen; Yi Yan; Xinzhong Li; Guojun Chen; Nvqin He; Shuxin Shen; Gangbin Chen; Chuanxi Zhang; Wangjun Liao; Yulin Liao; Jianping Bin
Journal:  Sci Rep       Date:  2016-02-25       Impact factor: 4.379

7.  Phosphorylation of calcium/calmodulin-stimulated protein kinase II at T286 enhances invasion and migration of human breast cancer cells.

Authors:  Mengna Chi; Hamish Evans; Jackson Gilchrist; Jack Mayhew; Alexander Hoffman; Elizabeth Ann Pearsall; Helen Jankowski; Joshua Stephen Brzozowski; Kathryn Anne Skelding
Journal:  Sci Rep       Date:  2016-09-08       Impact factor: 4.379

8.  CEACAM1 regulates the IL-6 mediated fever response to LPS through the RP105 receptor in murine monocytes.

Authors:  Zhifang Zhang; Deirdre La Placa; Tung Nguyen; Maciej Kujawski; Keith Le; Lin Li; John E Shively
Journal:  BMC Immunol       Date:  2019-01-23       Impact factor: 3.615

Review 9.  Signaling by epithelial members of the CEACAM family - mucosal docking sites for pathogenic bacteria.

Authors:  Arnaud Kengmo Tchoupa; Tamara Schuhmacher; Christof R Hauck
Journal:  Cell Commun Signal       Date:  2014-04-15       Impact factor: 5.712

10.  CEACAM1 controls the EMT switch in murine mammary carcinoma in vitro and in vivo.

Authors:  Florian Wegwitz; Eva Lenfert; Daniela Gerstel; Lena von Ehrenstein; Julia Einhoff; Geske Schmidt; Matthew Logsdon; Johanna Brandner; Gisa Tiegs; Nicole Beauchemin; Christoph Wagener; Wolfgang Deppert; Andrea Kristina Horst
Journal:  Oncotarget       Date:  2016-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.